X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
indazoles - pharmacology (2508) 2508
science & technology (2290) 2290
life sciences & biomedicine (2210) 2210
animals (2177) 2177
male (1365) 1365
humans (1338) 1338
rats (1083) 1083
pharmacology & pharmacy (915) 915
enzyme inhibitors - pharmacology (739) 739
mice (717) 717
nitric oxide (549) 549
female (547) 547
nitric oxide synthase - antagonists & inhibitors (506) 506
indazoles - chemistry (466) 466
neurosciences & neurology (457) 457
neurosciences (436) 436
dose-response relationship, drug (413) 413
rats, sprague-dawley (406) 406
oncology (374) 374
cell line, tumor (359) 359
antineoplastic agents - pharmacology (336) 336
biochemistry & molecular biology (335) 335
indazoles - therapeutic use (331) 331
rats, wistar (322) 322
structure-activity relationship (310) 310
indazoles - chemical synthesis (303) 303
indazoles - administration & dosage (260) 260
ng-nitroarginine methyl ester - pharmacology (258) 258
nitric oxide - metabolism (254) 254
chemistry (247) 247
protein kinase inhibitors - pharmacology (232) 232
analysis (221) 221
chemistry, medicinal (220) 220
physical sciences (214) 214
in vitro techniques (201) 201
cell proliferation - drug effects (199) 199
cell biology (196) 196
nitric oxide synthase type i (195) 195
pyrazoles - pharmacology (193) 193
nitric oxide synthase - metabolism (188) 188
imidazoles - pharmacology (187) 187
nitric oxide - physiology (186) 186
7-nitroindazole (185) 185
indazoles - pharmacokinetics (183) 183
molecular structure (179) 179
signal transduction - drug effects (173) 173
cells, cultured (170) 170
disease models, animal (169) 169
time factors (168) 168
sulfonamides - pharmacology (161) 161
nitric oxide synthase (156) 156
apoptosis - drug effects (155) 155
cancer (147) 147
arginine - pharmacology (141) 141
indazoles - metabolism (141) 141
models, molecular (141) 141
indoles - pharmacology (139) 139
adult (136) 136
middle aged (135) 135
physiology (135) 135
apoptosis (132) 132
signal transduction (132) 132
research (130) 130
cell survival - drug effects (128) 128
mice, inbred c57bl (126) 126
blood pressure - drug effects (121) 121
indazoles - adverse effects (119) 119
nitric oxide synthase type i - antagonists & inhibitors (118) 118
cell line (117) 117
drug synergism (115) 115
drug design (111) 111
chemistry, organic (108) 108
drug interactions (107) 107
xenograft model antitumor assays (105) 105
kinetics (103) 103
aged (101) 101
guanylate cyclase - metabolism (101) 101
administration, oral (100) 100
physiological aspects (99) 99
axitinib (97) 97
indazoles (97) 97
antineoplastic agents - therapeutic use (96) 96
proteins (96) 96
enzyme activators - pharmacology (95) 95
neoplasms - drug therapy (95) 95
immunohistochemistry (93) 93
mutation (93) 93
research article (93) 93
blotting, western (92) 92
antineoplastic agents - chemistry (91) 91
indazole (91) 91
yc-1 (91) 91
neurons - drug effects (90) 90
pharmacology/toxicology (90) 90
phosphorylation (89) 89
kinases (88) 88
nitric oxide synthase type i - metabolism (88) 88
abridged index medicus (87) 87
rabbits (87) 87
mice, nude (86) 86
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3120) 3120
Japanese (47) 47
German (24) 24
Chinese (22) 22
Russian (18) 18
Hungarian (6) 6
French (5) 5
Italian (5) 5
Portuguese (4) 4
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature communications, ISSN 2041-1723, 10/2017, Volume 8, Issue 1, pp. 1090 - 19
Journal Article
by Zhou, S and Liu, L and Li, H and Eilers, G and Kuang, Y and Shi, S and Yan, Z and Li, X and Corson, J M and Meng, F and Zhou, H and Sheng, Q and Fletcher, J A and Ou, W-B
British journal of cancer, ISSN 1532-1827, 04/2014, Volume 110, Issue 10, pp. 2479 - 2488
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2014, Volume 50, Issue 17, pp. 3021 - 3028
Journal Article
The Journal of pharmacology and experimental therapeutics, ISSN 0022-3565, 06/2009, Volume 329, Issue 3, pp. 928 - 937
Journal Article
Molecular cancer therapeutics, ISSN 1538-8514, 07/2007, Volume 6, Issue 7, pp. 2012 - 2021
With the development of targeted therapeutics, especially for small-molecule inhibitors, it is important to understand whether the observed in vivo efficacy... 
kinase inhibitor | Pharmacodynamics | pazopanib | angiogenesis | VEGF | Life Sciences & Biomedicine | Oncology | Science & Technology | Pyrimidines - blood | Humans | Fibroblast Growth Factor 2 - pharmacology | Antineoplastic Agents - administration & dosage | Indazoles - administration & dosage | Sulfones - pharmacology | Neovascularization, Pathologic - pathology | Phosphotyrosine - metabolism | Dose-Response Relationship, Drug | Sulfonamides - blood | Inhibitory Concentration 50 | Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors | Female | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Cornea - pathology | Phosphorylation - drug effects | Sulfones - blood | Vascular Endothelial Growth Factor A - pharmacology | Protein Kinase Inhibitors - pharmacokinetics | Pyrimidines - administration & dosage | Pyrimidines - pharmacology | Sulfones - pharmacokinetics | Sulfonamides - pharmacology | Protein Kinase Inhibitors - blood | Sulfonamides - pharmacokinetics | Indazoles - pharmacology | Protein Kinase Inhibitors - administration & dosage | Indazoles - blood | Animals | Indazoles - pharmacokinetics | Cell-Free System | Mice, Nude | Antineoplastic Agents - blood | Cell Line, Tumor | Pyrimidines - pharmacokinetics | Mice | Protein Kinase Inhibitors - pharmacology | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Index Medicus
Journal Article
Investigational new drugs, ISSN 0167-6997, 8/2013, Volume 31, Issue 4, pp. 833 - 844
The HGF/MET signaling pathway regulates a wide variety of normal cellular functions that can be subverted to support neoplasia, including cell proliferation,... 
Medicine & Public Health | MET inhibitor | Oncology | MST1R | Pharmacology/Toxicology | LY2801653 | ROS1 | MKNK | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Niacinamide - analogs & derivatives | Proto-Oncogene Proteins c-met - metabolism | Tetrazoles - pharmacology | Blood Vessels - pathology | Humans | Biological Availability | Antineoplastic Agents - administration & dosage | Indazoles - administration & dosage | Protein Kinase Inhibitors - chemistry | Tetrazoles - chemistry | Niacinamide - chemistry | Tetrazoles - administration & dosage | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Antineoplastic Agents - pharmacology | Indazoles - chemistry | Administration, Oral | Proto-Oncogene Proteins c-met - antagonists & inhibitors | Antineoplastic Agents - chemistry | Mutation - genetics | Receptor Protein-Tyrosine Kinases - metabolism | Niacinamide - administration & dosage | Indazoles - pharmacology | Xenograft Model Antitumor Assays | Protein Kinase Inhibitors - administration & dosage | Animals | Blood Vessels - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Niacinamide - pharmacology | Complications and side effects | Enzyme inhibitors | Physiological aspects | Genetic aspects | Cellular signal transduction | Dosage and administration | Research | Drug therapy | Cancer | Studies | Pharmaceutical sciences | Tumors | Index Medicus | Preclinical Studies
Journal Article
Journal Article
Journal Article